<!--The Official Report of Parliamentary Debates (Hansard) of the Legislative Council and the House of Assembly of the Parliament of South Australia are covered by parliamentary privilege. Republication by others is not afforded the same protection and may result in exposure to legal liability if the material is defamatory. You may copy and make use of excerpts of proceedings where (1) you attribute the Parliament as the source, (2) you assume the risk of liability if the manner of your use is defamatory, (3) you do not use the material for the purpose of advertising, satire or ridicule, or to misrepresent members of Parliament, and (4) your use of the extracts is fair, accurate and not misleading. Copyright in the Official Report of Parliamentary Debates is held by the Attorney-General of South Australia.-->
<hansard id="" tocId="" xml:lang="EN-AU" schemaVersion="4.0" xsi:noNamespaceSchemaLocation="hansard_1_0.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2007/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <name>Legislative Council</name>
  <date date="2023-02-07T14:15:00+10:30" />
  <sessionName>Fifty-Fifth Parliament, First Session (55-1)</sessionName>
  <parliamentNum>55</parliamentNum>
  <sessionNum>1</sessionNum>
  <parliamentName>Parliament of South Australia</parliamentName>
  <house>Legislative Council</house>
  <venue></venue>
  <reviewStage>published</reviewStage>
  <startPage num="1817" />
  <endPage num="1878" />
  <dateModified time="2023-07-06T09:44:09+09:30" />
  <proceeding continued="true">
    <name>Answers to Questions</name>
    <subject>
      <name>Japanese Encephalitis Vaccine</name>
      <text id="20230207414a459761ef4ef180000667">
        <inserted>
          <heading>Japanese Encephalitis Vaccine</heading>
        </inserted>
      </text>
      <talker role="member" id="6706" referenceid="c8683bcbb226495ebf16e224a5e3db3c" kind="question">
        <name>The Hon. N.J. CENTOFANTI</name>
        <house>Legislative Council</house>
        <portfolios>
          <portfolio id="">
            <name>Leader of the Opposition</name>
          </portfolio>
        </portfolios>
        <questions>
          <question date="2023-02-07T03:45:00+10:30" qonNum="166">
            <name>Japanese Encephalitis Vaccine</name>
          </question>
        </questions>
        <text id="20230207414a459761ef4ef180000668">
          <inserted>166 <by role="member" id="6706" referenceid="c8683bcbb226495ebf16e224a5e3db3c">The Hon. N.J. CENTOFANTI (Leader of the Opposition) </by>().21 October 2022).  </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000669">
          <inserted>1.&amp;#x9;What is the total funding provided by the commonwealth to SA Health for the purchase of Japanese encephalitis vaccines for human mitigation purposes since 1 January 2022?</inserted>
        </text>
        <text id="20230207414a459761ef4ef180000670">
          <inserted>2.&amp;#x9;What is the total value of Japanese encephalitis vaccines purchased by SA Health for human mitigation purposes since 1 January 2022?</inserted>
        </text>
        <text id="20230207414a459761ef4ef180000671">
          <inserted>3.&amp;#x9;Is SA Health administering a Japanese encephalitis vaccine program through its local health networks or has a third party/parties been engaged to administer the vaccine program? </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000672">
          <inserted>4.&amp;#x9;How many Japanese encephalitis vaccines have been administered in South Australia since 1 January 2022?</inserted>
        </text>
        <text id="20230207414a459761ef4ef180000673">
          <inserted>5.&amp;#x9;How many Japanese encephalitis vaccines are estimated to be administered in the financial year 2022-23?</inserted>
        </text>
      </talker>
      <talker role="member" id="4697" referenceid="c1607c57d2294390bdc2b07c15f35010" kind="answer">
        <name>The Hon. K.J. MAHER</name>
        <house>Legislative Council</house>
        <portfolios>
          <portfolio id="">
            <name>Minister for Aboriginal Affairs</name>
          </portfolio>
          <portfolio id="">
            <name>Attorney-General</name>
          </portfolio>
          <portfolio id="">
            <name>Minister for Industrial Relations and Public Sector</name>
          </portfolio>
        </portfolios>
        <questions>
          <question date="2023-02-07T03:45:00+10:30" qonNum="166">
            <name>Japanese Encephalitis Vaccine</name>
          </question>
        </questions>
        <text id="20230207414a459761ef4ef180000674">
          <inserted>
            <by role="member" id="4697" referenceid="c1607c57d2294390bdc2b07c15f35010">The Hon. K.J. MAHER (Minister for Aboriginal Affairs, Attorney-General, Minister for Industrial Relations and Public Sector):</by>  The Minister for Health and Wellbeing has advised:</inserted>
        </text>
        <text id="20230207414a459761ef4ef180000675">
          <inserted>The total funding provided by the commonwealth to SA Health for the purchase of Japanese encephalitis vaccines for human mitigation purposes since 1 January 2022 is $5.1 million (including GST). </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000676">
          <inserted>The total value of Japanese encephalitis vaccines purchased by SA Health for human mitigation purposes since 1 January 2022 is $1.5 million (including GST). </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000677">
          <inserted>SA Health is administering the Japanese encephalitis vaccination program through its Local Health Networks, participating GPs and pharmacies in the eligible zones. The engagement of third parties will be used if additional staffing and clinics are required due to vaccine demand.  </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000678">
          <inserted>Since 1 January 2022, approximately 21,250 Japanese encephalitis vaccines have been administered in South Australia.  </inserted>
        </text>
        <text id="20230207414a459761ef4ef180000679">
          <inserted>Currently, up to 24,000 Japanese encephalitis vaccines have been made available for the program and the aim is to administer most of these within the 2022-23 financial year. </inserted>
        </text>
      </talker>
    </subject>
  </proceeding>
</hansard>